Related Experiment Video
Updated: May 4, 2026

In Vitro Cleavage Assays using Purified Recombinant Drosophila Caspases for Substrate Screening
Published on: October 6, 2022
The contribution of Cdc2 in rotenone-induced G2/M arrest and caspase-3-dependent apoptosis
Hongcai Wang1, Zhentao Zhang, Jinsha Huang
1Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jie Fang Road, Wuhan, 430022, Hubei, China.
Abstract:
Neuronal cell cycle reentry maintained in a G2-like state before cell death, has been confirmed in dopaminergic neurons of patients with Parkinson's disease (PD). Caspase-3 is a final effector in apoptotic dopaminergic neurons in patients. The association of aberrant G2/M regulation with caspase-3 dependent apoptosis remains to be elucidated. Cell division cycle protein 2 (Cdc2) is a key player in G2/M transition in mitotic cells. Although the deregulation of Cdc2 correlated with the control of apoptosis in neurons, the molecular pathway by which Cdc2 involves in apoptosis is not clear. In a rotenone-based cell model of PD, we demonstrated that rotenone arrested cell cycle at G2/M phase and activated caspase-3 both in cytoplasm and nucleus. The decreased activity of Cdc2 by roscovitine or rotenone enhanced G2/M arrest. The increased cells in G2/M arrest by rotenone upregulated the expression of Cdc2. Suppression of Cdc2 expression downregulated cleaved caspase-3/9 and delayed cell apoptosis. Used together, the upregulation of Cdc2 contributes to rotenone-induced caspase-3/9-dependent apoptosis, which is associated with the enhancement of G2/M arrest. Our results suggest the deregulation of Cdc2 as a transition between cell cycle arrest and cell death.
Insights
Parkinson's disease (PD) involves dopaminergic neuron death linked to cell cycle reentry. Cdc2 deregulation contributes to this cell death by enhancing G2/M arrest and caspase-3/9 dependent apoptosis.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Biology
Background:
- Neuronal cell cycle reentry in a G2-like state precedes cell death in Parkinson's disease (PD) dopaminergic neurons.
- Caspase-3 is a key effector in the apoptosis of these neurons, but its link to aberrant G2/M regulation is unclear.
- Cell division cycle protein 2 (Cdc2) regulates G2/M transition, and its deregulation is implicated in neuronal apoptosis, though the mechanism is not fully understood.
Purpose of the Study:
- To investigate the role of Cdc2 deregulation in the G2/M arrest and caspase-3/9 dependent apoptosis of dopaminergic neurons in a rotenone-induced Parkinson's disease model.
- To elucidate the molecular pathway connecting Cdc2 activity, cell cycle arrest, and apoptosis.
Main Methods:
- Utilized a rotenone-based cell model to mimic Parkinson's disease.
- Assessed cell cycle progression (G2/M phase), caspase-3 activation, and Cdc2 expression and activity.
- Employed roscovitine and Cdc2 expression suppression to modulate cell cycle and apoptosis.
Main Results:
- Rotenone induced G2/M cell cycle arrest and activated caspase-3 in both cytoplasmic and nuclear compartments.
- Decreased Cdc2 activity (via roscovitine or rotenone) exacerbated G2/M arrest.
- Rotenone treatment upregulated Cdc2 expression, leading to enhanced G2/M arrest.
- Suppression of Cdc2 expression reduced cleaved caspase-3/9 levels and delayed apoptosis.
Conclusions:
- Upregulation of Cdc2 is a key factor in rotenone-induced, caspase-3/9 dependent apoptosis in a Parkinson's disease model.
- Cdc2 deregulation acts as a critical link between cell cycle arrest and cell death in this context.
- These findings highlight Cdc2 as a potential therapeutic target for Parkinson's disease.
Related Concept Videos
Caspases
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Negative Regulator Molecules
Cellular Injury V: Apoptosis and Autophagy

